IMBIORAY
Imbioray is a biotechnology company that specializes in cellular immunotherapy for tumors and immune diseases. The company engages in the development of global CAR-NK and tiNK cell therapy drugs and is committed to solving the treatment of clinically unmet diseases.
IMBIORAY
Industry:
Biotechnology Medical Therapeutics
Founded:
2014-01-01
Status:
Active
Total Funding:
0
Investors List
Lucky Source Funds
Lucky Source Funds investment in Venture Round - Imbioray